#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
APH_3____Ib.3002639.AF313472.15593_16397.545	APH_3____Ib.3002639.AF313472.15593_16397.545	1	0	16	24	APH_3____Ib+	804	101	100.0	APH_3____Ib+.l15.c4.ctg.1	101	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	APH(3'')-Ib;APH(3'')-Ib is an aminoglycoside phosphotransferase encoded by plasmids, transposons, integrative conjugative elements and chromosomes in Enterobacteriaceae and Pseudomonas spp.
APH_6__Ic.3002659.X01702.484_1285.404	APH_6__Ic.3002659.X01702.484_1285.404	1	0	27	852	APH_6__Ic	801	801	100.0	APH_6__Ic.l15.c4.ctg.1	1422	31.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	APH(6)-Ic is a transposon-encoded aminoglycoside phosphotransferase in S. enterica, P. aeruginosa and E. coli;APH(6)-Ic
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1062	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1311	43.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	429	431	ACG	55;54;54	A;C;G	55;54;53	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	L121Q	0	.	.	361	363	CTG	360	362	CTG	149;148;145	C;T;G	149;146;144	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	Q125E	0	.	.	373	375	CAG	372	374	CAG	157;159;161	C;A;G	156;158;160	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	Q125R	0	.	.	373	375	CAG	372	374	CAG	157;159;161	C;A;G	156;158;160	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	Q125K	0	.	.	373	375	CAG	372	374	CAG	157;159;161	C;A;G	156;158;160	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	Y161C	0	.	.	481	483	TAC	480	482	TAC	179;174;171	T,A;A;C	177,1;173;171	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	Y161D	0	.	.	481	483	TAC	480	482	TAC	179;174;171	T,A;A;C	177,1;173;171	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	Y161N	0	.	.	481	483	TAC	480	482	TAC	179;174;171	T,A;A;C	177,1;173;171	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	G317D	0	.	.	949	951	GGC	948	950	GGC	141;143;140	G;G;C,A	139;141;139,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1125	1127	GCA	88;86;88	G,A;C;A	75,1;78;87	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1125	1127	GCA	88;86;88	G,A;C;A	75,1;78;87	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1134	1136	GAA	84;83;84	G;A;A	83;81;82	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	0	HET	.	.	.	C210T	.	210	210	C	209	209	C	128	C,T	74,54	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	0	HET	.	.	.	T135C	.	135	135	T	134	134	T	96	T,C	57,30	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	1165	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1165	139.2	0	HET	.	.	.	C954T	.	954	954	C	953	953	C	130	C,T	62,66	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	68	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	136	13.7	1	SNP	p	A376S	0	.	.	1126	1128	GCA	9	11	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	68	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	136	13.7	1	SNP	p	A376V	0	.	.	1126	1128	GCA	9	11	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3556	Escherichia_coli_EF_Tu	1185	68	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	136	13.7	1	SNP	p	E379K	0	.	.	1135	1137	GAA	18	20	GAA	1;2;2	G;A;A	1;2;2	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1384	Escherichia_coli_mutant_1	1359	1359	99.78	Escherichia_coli_mutant_1.l6.c30.ctg.1	1947	37.5	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1652	1654	AAA	22;22;20	A;A;A	22;22;20	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1784	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1854	50.8	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1287	1289	GAA	67;66;66	G;A;A	67;66;66	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	354	H_NS	414	414	99.03	H_NS.l6.c17.ctg.1	970	19.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	238	G	234	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	230	C	229	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	217	C,G	214,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	232	T	229	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	249	C	248	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	214	C	213	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	230	A	230	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	233	A	233	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	239	A	239	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	245	T	240	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	246	C	246	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	239	C	236	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	243	A	242	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	245	G	245	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	244	C	243	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	247	T	245	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	285	G	285	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	301	G	300	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	304	T,G	302,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	230	T	230	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	219	G,T	217,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	195	C	193	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	186	A	181	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	156	C	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	145	C	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	42	A	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	42	A	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	35	G	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	29	C	29	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	108	T	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	123	G	123	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	116	T	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.1	545	229.6	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	252	C	251	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	161	94.41	Pasteurella_multocida_16S.l15.c30.ctg.5	179	107.1	0	.	n	.	0	T289C	SNP	289	289	T	19	19	C	30	C	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	161	94.41	Pasteurella_multocida_16S.l15.c30.ctg.5	179	107.1	0	.	n	.	0	A303G	SNP	303	303	A	33	33	G	85	G	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	161	94.41	Pasteurella_multocida_16S.l15.c30.ctg.5	179	107.1	0	.	n	.	0	G375A	SNP	375	375	G	105	105	A	102	A	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	161	94.41	Pasteurella_multocida_16S.l15.c30.ctg.5	179	107.1	0	.	n	.	0	G383C	SNP	383	383	G	113	113	C	50	C	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	161	94.41	Pasteurella_multocida_16S.l15.c30.ctg.5	179	107.1	0	.	n	.	0	G385C	SNP	385	385	G	115	115	C	34	C,A	33,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	161	94.41	Pasteurella_multocida_16S.l15.c30.ctg.5	179	107.1	0	.	n	.	0	C388G	SNP	388	388	C	118	118	G	17	G	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	161	94.41	Pasteurella_multocida_16S.l15.c30.ctg.5	179	107.1	0	.	n	.	0	C394T	SNP	394	394	C	124	124	T	6	T	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	161	94.41	Pasteurella_multocida_16S.l15.c30.ctg.5	179	107.1	0	.	n	.	0	A411T	SNP	411	411	A	141	141	T	7	T	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	161	94.41	Pasteurella_multocida_16S.l15.c30.ctg.5	179	107.1	0	.	n	.	0	T439A	SNP	439	439	T	169	169	A	4	A	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	136	90.44	Pasteurella_multocida_16S.l15.c30.ctg.7	136	32.5	0	.	n	.	0	C990G	SNP	990	990	C	33	33	G	16	G	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	136	90.44	Pasteurella_multocida_16S.l15.c30.ctg.7	136	32.5	0	.	n	.	0	T1002A	SNP	1002	1002	T	45	45	A	29	A	29	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	136	90.44	Pasteurella_multocida_16S.l15.c30.ctg.7	136	32.5	0	.	n	.	0	A1004G	SNP	1004	1004	A	47	47	G	33	G	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	136	90.44	Pasteurella_multocida_16S.l15.c30.ctg.7	136	32.5	0	.	n	.	0	C1011T	SNP	1011	1011	C	54	54	T	33	T	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	136	90.44	Pasteurella_multocida_16S.l15.c30.ctg.7	136	32.5	0	.	n	.	0	C1023A	SNP	1023	1023	C	66	66	A	43	A	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	136	90.44	Pasteurella_multocida_16S.l15.c30.ctg.7	136	32.5	0	.	n	.	0	T1024A	SNP	1024	1024	T	67	67	A	44	A	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	136	90.44	Pasteurella_multocida_16S.l15.c30.ctg.7	136	32.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	84	84	G	69	G	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	5092	Pasteurella_multocida_16S	1551	136	90.44	Pasteurella_multocida_16S.l15.c30.ctg.7	136	32.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	85	85	T	68	T	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1406	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1724	43.2	0	.	p	.	0	H2R	NONSYN	4	6	CAT	308	310	CGT	39;40;38	C;G;T	39;39;38	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1406	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1724	43.2	0	.	p	.	0	V30I	NONSYN	88	90	GTC	392	394	ATC	53;51;50	A,G;T;C	52,1;51;50	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1406	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1724	43.2	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1151	1153	GGC	48;47;46	G;G;C	48;47;45	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2076	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2266	48.6	0	.	p	.	0	R8S	NONSYN	22	24	AGA	336	338	AGC	25;25;25	A;G;C	25;25;25	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2076	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2266	48.6	0	.	p	.	0	I142L	NONSYN	424	426	ATA	738	740	CTA	45;45;45	C;T,G;A	44;44,1;45	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2076	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2266	48.6	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1257	1259	CAA	76;77;79	C;A;A	75;77;78	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2076	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2266	48.6	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1356	1358	GGT	89;90;89	G;G;T,C	88;89;88,1	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2076	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2266	48.6	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1926	1928	GTT	47;43;42	G;T;T	47;42;42	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	814	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1693	25.3	0	.	p	.	0	A125E	NONSYN	373	375	GCA	615	617	GAA	35;35;36	G;A;A	35;35;36	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	814	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1693	25.3	0	.	p	.	0	M185T	NONSYN	553	555	ATG	795	797	ACC	26;26;27	A;C;C	26;25;27	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	814	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1693	25.3	0	.	p	.	0	S225T	NONSYN	673	675	TCC	915	917	ACT	21;20;19	A;C;T	21;20;18	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	814	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1693	25.3	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1305	1307	ATC	17;17;19	A;T;C	16;17;19	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1222	PmrF	969	969	99.38	PmrF.l15.c17.ctg.1	1579	40.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	44	TEM_1+	858	209	98.56	TEM_1+.l6.c30.ctg.1	209	2.3	0	.	p	.	0	V82I	NONSYN	244	246	GTT	122	124	ATT	1;1;1	A;T;T	1;1;1	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	44	TEM_1+	858	215	99.53	TEM_1+.l6.c30.ctg.2	215	2.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	44	TEM_1+	858	77	98.7	TEM_1+.l6.c30.ctg.3	144	2.2	0	.	p	.	0	F19L	NONSYN	55	57	TTT	122	124	CTT	4;2;2	C;T;T	4;2;2	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	16	76	acrB	3147	242	91.32	acrB.l6.c4.ctg.1	248	8.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.;acrB
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3438	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3723	48.8	0	.	p	.	0	T85I	NONSYN	253	255	ACC	605	607	ATC	53;53;54	A;T;C	52;53;54	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3438	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3723	48.8	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2318	2320	AAG	32;31;31	A;A;G	32;31;31	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1372	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1734	41.9	0	.	p	.	0	A22V	NONSYN	64	66	GCC	332	334	GTC	24;22;21	G;T;C	24;22;21	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1372	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1734	41.9	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1073	1075	TGC	44;45;50	T;G;C	44;45;50	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	512	3224	acrF	3105	2598	98.5	acrF.l6.c17.ctg.1	3141	53.6	0	.	p	.	0	S46trunc	TRUNC	136	136	T	416	416	T	24	T	24	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	512	3224	acrF	3105	2598	98.5	acrF.l6.c17.ctg.1	3141	53.6	0	.	p	.	0	G148D	NONSYN	442	444	GGC	722	724	GAC	54;52;54	G;A;C	54;52;54	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	512	3224	acrF	3105	2598	98.5	acrF.l6.c17.ctg.1	3141	53.6	0	.	p	.	0	F240L	NONSYN	718	720	TTT	998	1000	TTA	33;33;30	T,C;T;A	32,1;33;30	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	512	3224	acrF	3105	2598	98.5	acrF.l6.c17.ctg.1	3141	53.6	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1181	1183	AAT	39;41;43	A;A;T	38;41;42	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	512	3224	acrF	3105	2598	98.5	acrF.l6.c17.ctg.1	3141	53.6	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1968	1968	T	79	T	77	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	512	3224	acrF	3105	199	97.49	acrF.l6.c17.ctg.2	199	3.0	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	137	139	AAG	4;4;4	A;A;G	4;4;4	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	768	acrR_2	648	648	99.54	acrR_2.l6.c30.ctg.1	1184	34.6	1	SNP	p	R45C	0	.	.	133	135	CGC	404	406	CGC	55;55;58	C;G;C	55;55;58	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	682	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1087	33.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	240	242	TTC	30;31;31	T;T;C	30;31;31	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	682	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1087	33.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	504	506	GGG	44;44;42	G;G;G	44;43;41	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	880	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1273	36.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	658	660	CTT	64;65;65	C;T,C;T	64;64,1;65	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3700	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3312	59.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2164	2166	GCA	92;93;94	G;C;A	90;92;94	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3700	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3312	59.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2425	2427	ACC	61;60;61	A;C;C	59;60;60	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3700	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3312	59.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2734	2736	GCC	38;40;42	G;C;C	38;39;42	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1682	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2543	34.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	364	366	GCT	10;11;14	G;C;T	10;11;14	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1682	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2543	34.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	484	486	GAG	4;2;2	G;A;G	4;2;2	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1682	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2543	34.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	520	522	TGC	11;11;13	T;G;C	11;11;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1682	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2543	34.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	703	705	GTT	26;26;29	G;T;T	26;26;29	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1682	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2543	34.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	853	855	CAC	38;38;37	C;A;C	38;38;37	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1682	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2543	34.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1138	1140	ATG	63;62;62	A;T;G	61;59;60	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1682	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2543	34.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2134	2136	CGC	28;28;28	C;G;C	28;28;27	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	804	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1432	29.6	0	.	p	.	0	S221T	NONSYN	661	663	AGC	979	981	ACC	22;22;22	A;C;C	22;21;22	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	804	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1432	29.6	0	.	p	.	0	P225S	NONSYN	673	675	CCG	991	993	TCG	17;18;18	T;C;G	17;18;18	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	718	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1256	30.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1200	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	2085	30.4	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1410	1412	AAA	12;12;12	A;A;A	10;12;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1200	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	2085	30.4	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1422	1424	GAG	13;14;14	G;A;G	11;10;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1200	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	2085	30.4	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1428	1430	CAC	16;17;17	C;A;C	15;16;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1200	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	2085	30.4	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1482	1484	GAG	25;24;24	G;A;G	25;23;24	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1528	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1975	41.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1004	cpxR	699	699	99.43	cpxR.l6.c30.ctg.1	1265	41.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	988	cysB	975	975	99.28	cysB.l15.c30.ctg.1	1470	35.6	0	.	p	.	0	A146T	NONSYN	436	438	GCT	725	727	ACT	55;53;57	A,G;C;T	52,3;53;57	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1248	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1760	37.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	920	922	GTC	43;42;42	G;T;C	42;40;42	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	2026	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2080	51.3	0	.	p	.	0	E197K	NONSYN	589	591	GAA	885	887	AAA	73;69;71	A,G;A;A	72,1;69;69	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1320	emrD	1191	1191	98.4	emrD.l15.c30.ctg.1	1853	37.7	0	.	p	.	0	G209S	NONSYN	625	627	GGC	949	951	AGC	46;45;43	A;G;C	46;45;43	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	38	emrE_1	333	93	96.77	emrE_1.l15.c4.ctg.3	93	11.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	924	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1669	29.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	859	861	AGG	23;27;27	A;G;G	23;27;27	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	924	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1669	29.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1249	1251	GAC	19;19;19	G;A;C	19;19;19	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	748	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1105	35.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1456	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2112	35.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	516	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1215	22.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	472	474	CTG	25;27;26	C;T;G	25;27;26	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	T38I	NONSYN	112	114	ACA	398	400	ATA	15;14;10	A;T;A	15;14;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	L42V	NONSYN	124	126	CTA	410	412	GTA	13;13;15	G;T;A	13;13;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	A93T	NONSYN	277	279	GCG	563	565	ACG	34;35;33	A;C;G	34;35;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	A114E	NONSYN	340	342	GCA	626	628	GAA	40;40;42	G;A;A	38;39;42	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	T127A	NONSYN	379	381	ACT	665	667	GCT	32;32;32	G;C;T	32;32;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	N133D	NONSYN	397	399	AAT	683	685	GAT	19;18;18	G;A;T	19;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	P162S	NONSYN	484	486	CCA	770	772	TCA	26;26;25	T;C;A	26;26;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	899	901	CAG	25;26;27	C;A;G	25;26;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1037	1039	GTT	23;22;23	G;T;T	23;22;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1193	1195	GAT	12;12;12	G;A;T	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1361	1363	AAT	25;25;24	A;A;T	25;25;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1382	1384	TTA	10;10;10	T;T;A	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1583	1585	AAA	23;24;24	A;A;A	23;24;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2318	2320	CAT	29;29;30	C;A;T	29;29;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2372	2374	CAT	18;19;19	C;A;T	18;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2390	2392	AGA	22;21;21	A;G;A	22;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2405	2407	AAT	27;26;26	A;A;T	27;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2552	2554	TCC	20;21;20	T;C;C	20;21;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2717	2719	ATT	34;34;34	A;T;T	34;34;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2738	2740	GAT	30;31;33	G;A;T	30;31;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2852	2854	GTT	32;31;32	G;T;T	32;30;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2686	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4212	33.8	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3137	3139	CAC	48;49;48	C;A;C	48;49;48	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1066	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1416	39.7	1	SNP	p	P64S	0	.	.	190	192	CCA	452	454	CCA	77;79;79	C;C;A	75;79;73	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1066	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1416	39.7	1	SNP	p	P64A	0	.	.	190	192	CCA	452	454	CCA	77;79;79	C;C;A	75;79;73	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1066	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1416	39.7	1	SNP	p	P64H	0	.	.	190	192	CCA	452	454	CCA	77;79;79	C;C;A	75;79;73	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1066	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1416	39.7	1	SNP	p	P64L	0	.	.	190	192	CCA	452	454	CCA	77;79;79	C;C;A	75;79;73	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1066	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1416	39.7	1	SNP	p	P64R	0	.	.	190	192	CCA	452	454	CCA	77;79;79	C;C;A	75;79;73	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	584	gadE	528	528	100.0	gadE.l15.c4.ctg.1	1165	26.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	231	95.67	gadW.l15.c30.ctg.1	338	19.2	0	.	p	.	0	C210F	NONSYN	628	630	TGT	130	132	TTT	6;6;7	T;T,G;T	6;0,6;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	231	95.67	gadW.l15.c30.ctg.1	338	19.2	0	.	p	.	0	S234A	NONSYN	700	702	TCG	202	204	GCG	14;14;14	G;C;G	14;14;14	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	239	93.31	gadW.l15.c30.ctg.2	241	10.5	0	.	p	.	0	I88M	NONSYN	262	264	ATA	42	44	ATG	5;5;5	A;T;G	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	239	93.31	gadW.l15.c30.ctg.2	241	10.5	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	45	47	CCG	5;5;5	C;C;G	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	239	93.31	gadW.l15.c30.ctg.2	241	10.5	0	.	p	.	0	D100E	NONSYN	298	300	GAC	78	80	GAA	3;4;4	G;A;A	3;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	239	93.31	gadW.l15.c30.ctg.2	241	10.5	0	.	p	.	0	P101S	NONSYN	301	303	CCC	81	83	TCC	4;4;4	T;C;C	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	239	93.31	gadW.l15.c30.ctg.2	241	10.5	0	.	p	.	0	R102G	NONSYN	304	306	CGG	84	86	GGG	4;4;4	G;G;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	239	93.31	gadW.l15.c30.ctg.2	241	10.5	0	.	p	.	0	K110N	NONSYN	328	330	AAA	108	110	AAT	9;9;9	A;A;T	9;9;9	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	179	94.41	gadW.l15.c30.ctg.3	179	3.0	0	.	p	.	0	H17Y	NONSYN	49	51	CAT	14	16	TAT	1;1;1	T;A;T	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	179	94.41	gadW.l15.c30.ctg.3	179	3.0	0	.	p	.	0	Q21H	NONSYN	61	63	CAA	26	28	CAT	1;1;1	C;A;T	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	179	94.41	gadW.l15.c30.ctg.3	179	3.0	0	.	p	.	0	L31V	NONSYN	91	93	CTG	56	58	GTG	2;2;2	G;T;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	179	94.41	gadW.l15.c30.ctg.3	179	3.0	0	.	p	.	0	D34E	NONSYN	100	102	GAT	65	67	GAG	2;2;2	G;A;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	179	94.41	gadW.l15.c30.ctg.3	179	3.0	0	.	p	.	0	L46P	NONSYN	136	138	CTG	101	103	CCG	2;3;3	C;C;G	2;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	186	gadW	729	179	94.41	gadW.l15.c30.ctg.3	179	3.0	0	.	p	.	0	E54D	NONSYN	160	162	GAA	125	127	GAT	5;7;7	G;A;T	5;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	586	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1275	24.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	442	444	TTA	24;24;23	T;T;A	24;24;23	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	586	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1275	24.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	520	522	ATT	22;21;21	A;T;T	22;21;21	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	586	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1275	24.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1021	1023	GGA	29;28;27	G;G;A	29;28;27	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	586	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1275	24.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1027	1029	CCG	27;27;27	C;C;G	27;27;27	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3332	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3299	53.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2379	2381	GAA	53;54;56	G;A;A	52;54;56	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3332	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3299	53.3	1	SNP	p	S83L	0	.	.	247	249	TCG	594	596	TCG	70;70;70	T;C;G	69;69;70	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3332	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3299	53.3	1	SNP	p	S83I	0	.	.	247	249	TCG	594	596	TCG	70;70;70	T;C;G	69;69;70	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3332	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3299	53.3	1	SNP	p	S83W	0	.	.	247	249	TCG	594	596	TCG	70;70;70	T;C;G	69;69;70	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3332	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3299	53.3	1	SNP	p	D87H	0	.	.	259	261	GAC	606	608	GAC	78;78;76	G;A;C	76;74;76	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3332	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3299	53.3	1	SNP	p	D87V	0	.	.	259	261	GAC	606	608	GAC	78;78;76	G;A;C	76;74;76	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3332	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3299	53.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	606	608	GAC	78;78;76	G;A;C	76;74;76	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3332	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3299	53.3	1	SNP	p	D87N	0	.	.	259	261	GAC	606	608	GAC	78;78;76	G;A;C	76;74;76	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3332	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3299	53.3	1	SNP	p	D87G	0	.	.	259	261	GAC	606	608	GAC	78;78;76	G;A;C	76;74;76	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2650	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3237	43.4	1	SNP	p	R136G	0	.	.	406	408	CGC	860	862	CGC	50;53;55	C;G;C	50;51;55	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2650	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3237	43.4	1	SNP	p	R136S	0	.	.	406	408	CGC	860	862	CGC	50;53;55	C;G;C	50;51;55	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2650	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3237	43.4	1	SNP	p	R136I	0	.	.	406	408	CGC	860	862	CGC	50;53;55	C;G;C	50;51;55	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2650	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3237	43.4	1	SNP	p	R136E	0	.	.	406	408	CGC	860	862	CGC	50;53;55	C;G;C	50;51;55	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2650	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3237	43.4	1	SNP	p	R136C	0	.	.	406	408	CGC	860	862	CGC	50;53;55	C;G;C	50;51;55	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2650	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3237	43.4	1	SNP	p	R136L	0	.	.	406	408	CGC	860	862	CGC	50;53;55	C;G;C	50;51;55	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2650	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3237	43.4	1	SNP	p	R136H	0	.	.	406	408	CGC	860	862	CGC	50;53;55	C;G;C	50;51;55	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	606	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1081	29.4	0	.	p	.	0	A72P	NONSYN	214	216	GCG	423	425	CCG	41;43;45	C;C;G	41;43;44	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	606	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1081	29.4	0	.	p	.	0	T123A	NONSYN	367	369	ACC	576	578	GCC	44;44;45	G;C;C	41;44;44	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1240	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1477	44.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	258	260	TCA	42;43;44	T;C;A	41;43;44	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	456	marA	384	384	99.74	marA.l15.c4.ctg.1	1051	22.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	594	596	AGC	14;14;14	A;G;C	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	696	698	CAT	9;8;8	C,A;A;T	7,1;7;8	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	V45E	0	.	.	133	135	GTG	420	422	GTG	37;39;37	G;T;G	37;39;36	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	I49S	0	.	.	145	147	ATC	432	434	ATC	43;43;44	A;T;C	43;43;44	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	A70T	0	.	.	208	210	GCA	495	497	GCA	22;22;23	G;C;A	22;22;23	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	R73S	0	.	.	217	219	CGT	504	506	CGT	24;24;24	C;G;T	24;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	R73C	0	.	.	217	219	CGT	504	506	CGT	24;24;24	C;G;T	24;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	R77C	0	.	.	229	231	CGC	516	518	CGC	21;21;22	C;G;C	21;21;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	R77L	0	.	.	229	231	CGC	516	518	CGC	21;21;22	C;G;C	21;21;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	L78M	0	.	.	232	234	CTG	519	521	CTG	21;21;21	C;T;G	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	R94S	0	.	.	280	282	CGC	567	569	CGC	12;12;12	C;G;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	R94H	0	.	.	280	282	CGC	567	569	CGC	12;12;12	C;G;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	276	marR	435	435	97.7	marR.l15.c4.ctg.1	943	15.3	1	SNP	p	V96E	0	.	.	286	288	GTA	573	575	GTA	12;13;13	G;T;A	12;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	S7F	NONSYN	19	21	TCC	207	209	TTC	5;5;5	T;T;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	R36I	NONSYN	106	108	AGG	294	296	ATC	32;31;30	A;T;C	32;31;30	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	E42A	NONSYN	124	126	GAA	312	314	GCC	13;13;13	G;C;C	12;13;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	N43V	NONSYN	127	129	AAT	315	317	GTG	13;14;13	G;T;G	13;14;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	E52D	NONSYN	154	156	GAG	342	344	GAT	16;15;15	G;A;T	16;15;15	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	N59T	NONSYN	175	177	AAC	363	365	ACC	15;15;15	A;C;C	15;15;15	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	I68L	NONSYN	202	204	ATA	390	392	TTA	13;11;12	T;T;A	13;11;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	531	533	CAG	57;55;56	C;A;G	57;55;56	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	570	572	GCC	44;44;47	G;C;C	44;44;47	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	675	677	GCG	32;32;33	G;C;G	32;30;33	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	L231F	NONSYN	691	693	CTT	879	881	TTT	21;23;24	T,G;T;T	0,17;23;23	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	898	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1670	28.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1041	1041	C	29	C	29	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1012	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1855	29.1	0	.	p	.	0	V12trunc	TRUNC	34	34	G	355	355	G	41	G	40	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1012	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1855	29.1	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	412	414	CAG	28;27;26	C;A;G	28;27;26	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1012	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1855	29.1	0	.	p	.	0	T83I	NONSYN	247	249	ACC	562	564	ATC	28;28;27	A;T;C	27;27;27	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1012	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1855	29.1	0	.	p	.	0	I99M	NONSYN	295	297	ATA	610	612	ATG	28;31;33	A;T;G	28;31;32	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1012	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1855	29.1	0	.	p	.	0	A130T	NONSYN	388	390	GCC	703	705	ACC	26;26;26	A;C;C	26;26;26	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1012	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1855	29.1	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1084	1086	ACG	56;56;58	A,C;C;G	55,1;56;58	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3594	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3605	52.6	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2060	2062	ACC	55;55;57	A;C;C	55;55;57	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3594	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3605	52.6	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2453	2455	CAA	41;37;37	C;A;A	41;35;36	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3594	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3605	52.6	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2621	2623	ATT	41;40;38	A;T;T	41;40;38	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3594	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3605	52.6	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2705	2707	GTT	49;49;50	G;T;T	49;49;50	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3594	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3605	52.6	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2813	2815	GAG	33;31;32	G;A;G	33;31;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3594	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3605	52.6	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3041	3043	ATG	44;44;45	A;T;G	44;44;45	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3594	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3605	52.6	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3176	3178	GAT	43;40;40	G;A;T	42;39;39	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3024	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3368	47.0	0	.	p	.	0	I46M	NONSYN	136	138	ATC	326	328	ATG	20;21;22	A;T;G	20;21;22	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3024	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3368	47.0	0	.	p	.	0	V208I	NONSYN	622	624	GTC	812	814	ATC	54;54;53	A;T;C	54;54;53	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3024	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3368	47.0	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3128	3130	CAC	11;11;11	C;A;C	11;11;11	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3024	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3368	47.0	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3131	3133	CTC	11;11;11	C;T;C	10;11;11	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1580	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2014	41.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	310	312	GAA	23;23;22	G;A;A	23;23;22	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1580	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2014	41.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	979	981	GCG	59;60;62	G;C;G	59;60;62	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1580	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2014	41.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1321	1323	ATC	68;70;69	A;T;C	67;69;68	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1580	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2014	41.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1624	1626	TTT	64;66;63	T;T;T	64;66;62	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1702	mdtE	1158	1158	99.31	mdtE.l15.c17.ctg.1	1738	51.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3860	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3706	55.2	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1196	1198	ACC	43;43;43	A;C,A;C	43;39,1;43	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3860	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3706	55.2	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2438	2440	GAC	53;55;55	G;A;C	52;54;54	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1428	mdtG	1227	1047	99.33	mdtG.l6.c17.ctg.1	1637	38.4	0	.	p	.	0	V200I	NONSYN	598	600	GTC	731	733	ATC	53;52;53	A,C;T;C	52,1;52;53	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1428	mdtG	1227	182	99.45	mdtG.l6.c17.ctg.3	447	20.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	269	271	GGA	5;6;6	G;G;A	5;6;6	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1244	mdtH	1209	1209	98.18	mdtH.l6.c4.ctg.1	1752	37.7	0	.	p	.	0	G134C	NONSYN	400	402	GGT	685	687	TGT	54;57;58	T;G;T	54;57;58	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1244	mdtH	1209	1209	98.18	mdtH.l6.c4.ctg.1	1752	37.7	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1255	1257	TTG	49;50;47	T;T;G	49;50;47	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1244	mdtH	1209	1209	98.18	mdtH.l6.c4.ctg.1	1752	37.7	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1465	1467	ACG	10;12;12	A;C;G	10;12;12	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1370	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1856	39.2	0	.	p	.	0	A185S	NONSYN	553	555	GCC	895	897	TCC	46;47;46	T;C;C	45;46;44	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1084	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1673	34.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	686	688	ATT	44;44;44	A;T;T	42;43;44	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	193	195	ATG	35;34;35	A;T;G	35;34;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	259	261	ATC	21;22;23	A;T;C	19;22;23	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	508	510	CGC	42;42;43	C;G;C	42;41;43	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	874	876	AGC	47;49;46	A;G;C	47;49;45	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1075	1077	GTG	45;43;42	G;T;G	44;41;42	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1138	1140	AAC	22;24;25	A;A;C	21;23;23	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1183	1185	GTC	47;48;48	G;T;C	45;45;47	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1213	1215	ATA	57;56;58	A;T;A	57;55;58	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1321	1323	TCT	49;49;49	T;C;T	48;48;48	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1708	1710	GCG	45;48;49	G;C;G	45;47;49	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2258	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2568	46.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1921	1923	ATC	55;55;56	A;T;C	54;55;56	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1334	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	2102	33.7	0	.	p	.	0	S129A	NONSYN	385	387	TCA	736	738	GCG	35;35;36	G;C;G	34;31;35	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1334	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	2102	33.7	0	.	p	.	0	A187T	NONSYN	559	561	GCC	910	912	ACC	48;48;47	A;C;C	48;48;47	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1334	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	2102	33.7	0	.	p	.	0	H211R	NONSYN	631	633	CAC	982	984	CGC	40;38;43	C;G;C	40;38;43	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1334	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	2102	33.7	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1099	1101	GCT	44;47;48	G;C;T	44;47;48	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1334	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	2102	33.7	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1183	1185	AAA	21;22;21	A;A;A	21;22;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1334	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	2102	33.7	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1201	1203	CGA	28;26;26	C;G;A	28;26;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1334	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	2102	33.7	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1366	1368	GCC	21;20;21	G;C;C	21;20;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1334	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	2102	33.7	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1378	1380	GAT	26;27;29	G;A;T	26;27;29	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1334	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	2102	33.7	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1795	1797	GCT	26;22;22	G;C;T	26;22;22	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3660	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3988	48.5	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1618	1620	AAG	52;52;52	A;A;G	51;52;52	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3660	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3988	48.5	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2695	2697	CTG	49;46;47	C;T;G	48;45;46	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	240	mgrB	144	144	100.0	mgrB.l15.c4.ctg.1	168	38.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2200	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2283	51.1	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1089	1091	AAC	55;56;56	A;A;C	55;56;56	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2200	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2283	51.1	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1635	1637	ATA	66;65;66	A;T;A	66;65;65	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1618	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1896	45.2	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1407	1409	GAT	72;75;78	G;A;T	71;75;76	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1618	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1896	45.2	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1410	1412	CTG	79;78;79	C;T;G	78;77;78	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	726	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1285	29.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	287	289	TGT	45;42;41	T;G;T	45;42;41	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	726	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1285	29.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	557	559	ACC	35;36;34	A;C;C	32;36;34	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	726	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1285	29.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	767	769	GAC	27;28;30	G;A;C	27;28;30	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	726	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1285	29.6	1	SNP	p	R15C	0	.	.	43	45	CGC	251	253	CGC	79;79;78	C;G;C	79;78;78	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	726	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1285	29.6	1	SNP	p	S33R	0	.	.	97	99	AGC	305	307	AGC	35;35;35	A;G;C	35;34;35	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	726	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1285	29.6	1	SNP	p	G131D	0	.	.	391	393	GGC	599	601	GGC	44;43;44	G;G;C	44;43;41	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	726	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1285	29.6	1	SNP	p	R203C	0	.	.	607	609	CGT	815	817	CGT	38;40;41	C;G;T	38;39;41	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	726	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1285	29.6	1	SNP	p	R203L	0	.	.	607	609	CGT	815	817	CGT	38;40;41	C;G;T	38;39;41	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1642	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1742	49.7	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1259	1261	GAG	66;66;62	G;A;G	66;66;60	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1642	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1742	49.7	1	SNP	p	G141E	0	.	.	421	423	GGT	746	748	GGT	88;87;86	G;G;T	88;86;83	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1642	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1742	49.7	1	SNP	p	G141D	0	.	.	421	423	GGT	746	748	GGT	88;87;86	G;G;T	88;86;83	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1642	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1742	49.7	1	SNP	p	R154A	0	.	.	460	462	CGT	785	787	CGT	79;80;79	C;G;T	78;79;77	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1642	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1742	49.7	1	SNP	p	R154D	0	.	.	460	462	CGT	785	787	CGT	79;80;79	C;G;T	78;79;77	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3194	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	61.3	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1845	1847	GTG	67;69;69	G;T,C;G	65;63,3;69	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3194	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	61.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1872	1874	TCG	78;77;78	T;C;G	73;74;75	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3194	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	61.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2487	2489	AAC	46;46;46	A;A;C	46;46;46	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3194	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	61.3	1	SNP	p	A85T	0	.	.	253	255	GCG	501	503	GCG	77;80;76	G;C;G	76;76;71	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3194	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	61.3	1	SNP	p	D111H	0	.	.	331	333	GAT	579	581	GAT	54;54;53	G;A;T	54;53;52	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3194	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	61.3	1	SNP	p	S129P	0	.	.	385	387	TCC	633	635	TCC	50;51;51	T;C;C	48;51;49	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1828	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2467	39.3	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1718	1720	AAC	67;69;66	A,G;A;C	65,2;69;66	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1828	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2467	39.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1727	1729	GAT	75;74;72	G;A;T	74;74;71	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1882	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1960	50.7	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	860	862	CAG	55;57;58	C;A,C;G	54;54,1;57	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1882	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1960	50.7	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1334	1336	GAT	54;52;53	G;A;T	54;52;53	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	V146F	0	.	.	436	438	GTT	759	761	GTT	66;63;63	G;T;T	65;63;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1860	1862	CAG	62;59;59	C;A;G	62;59;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1860	1862	CAG	62;59;59	C;A;G	62;59;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1899	1901	CAC	53;55;55	C;A;C	53;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1908	1910	CGT	53;56;57	C;G;T	53;56;57	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1908	1910	CGT	53;56;57	C;G;T	53;56;57	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1914	1916	TCC	60;61;60	T;C;C	60;60;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1920	1922	CTC	60;57;55	C;T;C	60;57;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	2010	2012	ACC	62;62;64	A;C,A;C	61;61,1;64	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	2013	2015	CCT	62;61;61	C;C;T,C	62;61;60,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5492	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4669	62.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2382	2384	CGT	93;92;88	C,A;G;T	90,1;91;87	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	.	n	.	0	A226G	SNP	226	226	A	307	307	G	458	G	457	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	1	SNP	n	A794T	0	.	.	794	794	A	875	875	A	407	A,C	400,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	1	SNP	n	A794G	0	.	.	794	794	A	875	875	A	407	A,C	400,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	1	SNP	n	G926T	0	.	.	926	926	G	1007	1007	G	404	G	402	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	1	SNP	n	G926C	0	.	.	926	926	G	1007	1007	G	404	G	402	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	1	SNP	n	G926A	0	.	.	926	926	G	1007	1007	G	404	G	402	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	1	SNP	n	A1519G	0	.	.	1519	1519	A	1600	1600	A	326	A	323	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	1	SNP	n	A1519T	0	.	.	1519	1519	A	1600	1600	A	326	A	323	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	1	SNP	n	A1519C	0	.	.	1519	1519	A	1600	1600	A	326	A	323	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	T273A	.	273	273	T	354	354	T	423	T,A	307,104	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	T1010C,G	.	1010	1010	T	1091	1091	T	448	T,C,G	256,182,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	C183T,A	.	183	183	C	264	264	C	364	C,T,A	274,87,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	T90C	.	90	90	T	171	171	T	419	T,C	318,100	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	A250T,C	.	250	250	A	331	331	A	432	A,T,C	329,100,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	G474A,C	.	474	474	G	555	555	G	472	G,A,C	348,117,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	A253T	.	253	253	A	334	334	A	434	A,T	334,99	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	C719T,A	.	719	719	C	800	800	C	428	C,T,A	242,181,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	C1038T	.	1038	1038	C	1119	1119	C	458	C,T	284,172	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	G1002A	.	1002	1002	G	1083	1083	G	448	G,A	252,195	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	G1006C	.	1006	1006	G	1087	1087	G	444	G,C	250,183	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	15070	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1637	442.9	0	HET	.	.	.	A79G	.	79	79	A	160	160	A	413	A,G	303,103	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	704	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1031	36.2	1	SNP	p	R20H	0	.	.	58	60	CGC	371	373	CGC	48;46;47	C;G;C	48;46;47	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	704	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1031	36.2	1	SNP	p	G121D	0	.	.	361	363	GGT	674	676	GGT	54;54;53	G;G;T	54;54;52	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	474	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	973	25.8	1	SNP	p	A12S	0	.	.	34	36	GCA	344	346	GCA	56;56;56	G;C;A	56;56;56	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	528	36	APH_6__Id+	837	225	99.56	APH_6__Id+.l15.c30.ctg.1	225	2.3	0	.	p	.	0	A201G	NONSYN	601	603	GCC	46	48	GGC	3;2;3	G;G,C;C	2;0,2;3	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	528	12	sul2	816	147	98.65	sul2.l6.c30.ctg.1	149	1.4	0	.	p	.	0	P89fs	FSHIFT	265	265	C	3	3	C	1	C	0	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	0	80	tetA	1200	184	100.0	tetA.l6.c30.ctg.1	184	2.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	0	80	tetA	1200	533	100.0	tetA.l6.c30.ctg.2	533	4.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	16	82	tetR	651	283	100.0	tetR.l15.c30.ctg.1	467	5.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1876	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	2074	47.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
